{
    "Trade/Device Name(s)": [
        "Carbon Dioxide Reagent Set"
    ],
    "Submitter Information": "Teco Diagnostics, Inc.",
    "510(k) Number": "K170200",
    "Predicate Device Reference 510(k) Number(s)": [
        "K070251"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "KHS"
    ],
    "Summary Letter Date": "April 26, 2017",
    "Summary Letter Received Date": "April 27, 2017",
    "Submission Date": "January 20, 2017",
    "Regulation Number(s)": [
        "21 CFR 862.1160"
    ],
    "Regulation Name(s)": [
        "Bicarbonate/carbon dioxide test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Carbon Dioxide",
        "Bicarbonate"
    ],
    "Specimen Type(s)": [
        "Serum"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "TC-MATRIX analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Enzymatic assay",
        "Spectrophotometric analysis"
    ],
    "Methodologies": [
        "Enzymatic; malate dehydrogenase and phosphoenolpyruvate carboxylase"
    ],
    "Submission Type(s)": [
        "Reagent",
        "Kit"
    ],
    "Document Summary": "FDA 510(k) summary for Teco Diagnostics Carbon Dioxide Reagent Set, an enzymatic quantitative assay for measuring carbon dioxide in human serum using a spectrophotometric method.",
    "Indications for Use Summary": "Intended for measurement of carbon dioxide level in human serum to aid in assessment of acid-base balance of metabolic alkalosis or respiratory acidosis; for in vitro diagnostic use only.",
    "fda_folder": "Clinical Chemistry"
}